Starling Oncology, Inc. (STLN) Stock

Healthcare · Medical Care Facilities · Member of Other US Stocks

Starling Oncology, Inc. (STLN) closed at USD 6.51 on 2026-10-14, a change of +39.1 % over the past year, with a market capitalization of USD 704.24M.

Starling Oncology, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Starling Oncology, Inc. key figures

Previous close

USD 6.51 (2026-10-14)

1-year change

+39.1 %

Market cap

USD 704.24M

Enterprise value

USD 767.94M

P/E ratio (trailing)

-23.03

P/E ratio (forward)

n/a

EPS (trailing)

-0.30

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-27.86

Revenue growth

34.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.23

Employees

641

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Starling Oncology, Inc.

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Starling Oncology, Inc. and compare it with other stocks.